Series date: 
Sunday, October 1, 2017 - 7:30am to Sunday, September 30, 2018 - 8:30am

COURSE DESCRIPTION:
The knowledge and interpretation of tumor genetics are playing an increasing role in the management of many malignancies. This knowledge has a great potential to improve the patient care and the health care system. To realize the full potential of this information, its role, benefit and challenges, it is crucial to have a thorough discussion among members of the MTB together with a strong leadership. The multidisciplinary approach has become crucial recently due to the ever-increasing complexity of medical knowledge and the huge wealth of information that is available to physicians, in addition to the complexity of the various medical procedures and interventions available for cancer care.

TARGET AUDIENCE:
Medical Oncologists, Radiation Oncologists, Surgeons, Pathologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists and Patient Care Facilitators. All personnel involved in Research and Genomic Medicine and in the care of the cancer patient.

LEARNING OBJECTIVES:

  • Interpret sophisticated genetic information from Next Generation Sequencing analysis
  • Implement optimal genetic strategies of treatment for cancer patients.
  • Utilize multiple disciplinary approaches to obtain material for diagnosis and treatment,
  • Determine cancer genetic profile using various laboratory modalities.
  • Understand mechanism of genetic progression, mutation and resistance, to be used to delineate new therapy.
  • Promote a multidisciplinary team approach by bridging gaps across the continuum of care in order to enhance the overall quality of patient-centered cancer care.

FACULTY & DISCLOSURE

Federico Albrecht, M.D.
Moderator

Federico Albrecht, M.D., has indicated that neither he nor his spouse/partner any relevant financial relationships to disclose and the discussions will not include mention of investigational or off-label usage. The core group of contributors has provided disclosures; complete disclosure statements will be included on the sign-in sheet for this activity.

Disclosure Policy and Disclaimer

ACCREDITATION

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-545851, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.

This activity has also been approved for 1 credit for Nursing, Laboratory Personnel, Occupational Therapy, Pharmacy and Respiratory Care (category personal growth). Baptist Health South Florida, CE Broker Provider #50-182. 

Radiology Technologist 1 credit FBRC Provider #3201106

Series location: 
Baptist Hospital
8900 N. Kendall Dr
Miami, FL 33176
United States

Sessions

Session Datesort descending
Molecular Tumor Board - October 3, 2017 10/03/2017 - 7:30am to 8:30am
Molecular Tumor Board - December 5, 2017 12/05/2017 - 7:30am to 8:30am
Molecular Tumor Board - January 16, 2018 01/16/2018 - 7:30am to 8:30am
Molecular Tumor Board - March 6, 2018 03/06/2018 - 7:30am to 8:30am
Molecular Tumor Board - April 3, 2018 04/03/2018 - 7:30am to 8:30am
Molecular Tumor Board - May 1, 2018 05/01/2018 - 7:30am to 8:30am